Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Complication and prognosis of juvenile idiopathic arthritis associated uveitis in the era of modern immunomodulatory (CROSBI ID 266863)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Barišić Kutija, Marija ; Perić, Sanja ; Knežević, Josip ; Juratovac, Zlatko ; Vukojević, Nenad Complication and prognosis of juvenile idiopathic arthritis associated uveitis in the era of modern immunomodulatory // Psychiatria Danubina, 31 (2019), 44-49

Podaci o odgovornosti

Barišić Kutija, Marija ; Perić, Sanja ; Knežević, Josip ; Juratovac, Zlatko ; Vukojević, Nenad

engleski

Complication and prognosis of juvenile idiopathic arthritis associated uveitis in the era of modern immunomodulatory

IA is the most common rheumatic disease of childhood and JIA-U is its most frequent and most devastating extraarticular manifestation. This form of uveitis is usually asymptomatic, chronic anterior uveitis, often accompained with complications. JIA-U is the main cause of vision loss and even blidness in childhood. Thus, screening for JIA-U in all JIA patients and early treatment is of prime importance. Over the last 15-20 years, ever since IMT has been used, studies generally show trends toward decrease of JIA-U onset, complications frequency, improvement of prognosis and remission achievement. Despite evident improvements, over 20% JIA-U patients still develop complications in long-term follow- up. Moreover, about 50% JIA-U patients continue to have active uveitis in adulthood. Therefore, JIA-U is still associated with high risk of late sequelae and visual acuity loss, functionally and structurally eye damage and quality of life impairment.

juvenile idiopathic arthritis ; uveitis ; functionally eye damage ; structurally eye damage ; quality of life

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

31

2019.

44-49

objavljeno

0353-5053

1849-0867

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost